These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 481551)

  • 1. Enhancement of memory by physostigmine.
    Davis KL; Mohs RC; Tinklenberg JR
    N Engl J Med; 1979 Oct; 301(17):946. PubMed ID: 481551
    [No Abstract]   [Full Text] [Related]  

  • 2. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of physostigmine and lecithin on memory in Alzheimer disease.
    Peters BH; Levin HS
    Ann Neurol; 1979 Sep; 6(3):219-21. PubMed ID: 534419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of physostigmine and scopolamine on the memory functions of chess players.
    Liljequist R; Mattila MJ
    Med Biol; 1979; 57(6):402-5. PubMed ID: 547122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human memory and the effects of physostigmine and choline chloride [proceedings].
    Davis KL; Mohs RC; Davis BM; Horvath TB; Tinklenberg JR; Rosenberg GS; Levy MI
    Psychopharmacol Bull; 1980 Oct; 16(4):27-8. PubMed ID: 7454927
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
    Mandel RJ; Chen AD; Connor DJ; Thal LJ
    J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine and its effect on six patients with dementia.
    Ashford JW; Soldinger S; Schaeffer J; Cochran L; Jarvik LF
    Am J Psychiatry; 1981 Jun; 138(6):829-30. PubMed ID: 7246817
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of BN-50730 (PAF receptor antagonist) and physostigmine (AChE inhibitor) on learning and memory in mice.
    Singh N; Sharma A; Singh M
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):585-8. PubMed ID: 9500121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspects of using psychological methods in studying the effects of psychotropic drugs].
    Slánská J
    Arzneimittelforschung; 1974 Aug; 24(8):1102. PubMed ID: 4479407
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved verbal learning after outpatient oral physostigmine therapy in patients with dementia of the Alzheimer type.
    Sevush S; Guterman A; Villalon AV
    J Clin Psychiatry; 1991 Jul; 52(7):300-3. PubMed ID: 2071560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Alzheimer disease by continuous intravenous infusion of physostigmine.
    Asthana S; Raffaele KC; Berardi A; Greig NH; Haxby JV; Schapiro MB; Soncrant TT
    Alzheimer Dis Assoc Disord; 1995; 9(4):223-32. PubMed ID: 8749612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of physostigmine on stimulus encoding in a memory-scanning task.
    Wetherell A
    Psychopharmacology (Berl); 1992; 109(1-2):198-202. PubMed ID: 1365656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physostigmine's impact on brief shock-induced hypoalgesia parallels its effect on memory.
    Meagher MW; Illich PA; Salinas JA
    Neurobiol Learn Mem; 1998 Nov; 70(3):374-87. PubMed ID: 9774528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.
    Litvan I; Blesa R; Clark K; Nichelli P; Atack JR; Mouradian MM; Grafman J; Chase TN
    Ann Neurol; 1994 Jul; 36(1):55-61. PubMed ID: 8024262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor antagonists antagonize the facilitatory effects of post-training intra-basolateral amygdala NMDA and physostigmine on passive avoidance learning.
    Jafari-Sabet M
    Eur J Pharmacol; 2006 Jan; 529(1-3):122-8. PubMed ID: 16337625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory restoration or memory block: differential effects of physostigmine depend on the age of the memory trace.
    Lukaszewska I; Dławichowska E
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):181-90. PubMed ID: 2130640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
    Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
    Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of drugs upon memory of patients with senile dementia.
    Delwaide PJ; Devoitille JM; Ylieff M
    Acta Psychiatr Belg; 1980; 80(5):748-54. PubMed ID: 7234458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of physostigmine on the perception and consolidation phase of memory and learning in alcoholics.
    Slánská J; Safratová V; Vojĕchovský M; Skála J
    Act Nerv Super (Praha); 1971; 13(3):201-2. PubMed ID: 4939833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.